The chemical substance with the name "(R)-3-(tert-Butyl)-N-[1-[4-[6-[6-(4-Boc-1-piperazinyl)-3-pyridyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-methylphenyl]ethyl]-1,2,4-oxadiazole-5-carboxamide" and CAS number "2736510-62-4" is a complex organic compound characterized by its multi-functional structure. It features a tert-butyl group, which contributes to its hydrophobic properties, and a piperazine moiety that may enhance its biological activity and solubility. The presence of an oxadiazole ring suggests potential applications in medicinal chemistry, particularly in drug development, due to its ability to participate in various chemical interactions. The compound's chirality, indicated by the (R) configuration, may influence its pharmacokinetics and pharmacodynamics, making it important for therapeutic efficacy. Additionally, the presence of multiple aromatic and heterocyclic components may contribute to its stability and reactivity. Overall, this compound exemplifies the complexity often found in pharmaceutical agents, combining various structural elements that can affect its biological properties and potential applications.

(R)-3-(tert-Butyl)-N-[1-[4-[6-[6-(4-Boc-1-piperazinyl)-3-pyridyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-methylphenyl]ethyl]-1,2,4-oxadiazole-5-carboxamide

2736510-62-4: The chemical substance with the name "(R)-3-(tert-Butyl)-N-[1-[4-[6-[6-(4-Boc-1-piperazinyl)-3-pyridyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-methylphenyl]ethyl]-1,2,4-oxadiazole-5-carboxamide" and CAS number "2736510-62-4" is a complex organic compound characterized by its multi-functional structure. It features a tert-butyl group, which contributes to its hydrophobic properties, and a piperazine moiety that may enhance its biological activity and solubility. The presence of an oxadiazole ring suggests potential applications in medicinal chemistry, particularly in drug development, due to its ability to participate in various chemical interactions. The compound's chirality, indicated by the (R) configuration, may influence its pharmacokinetics and pharmacodynamics, making it important for therapeutic efficacy. Additionally, the presence of multiple aromatic and heterocyclic components may contribute to its stability and reactivity. Overall, this compound exemplifies the complexity often found in pharmaceutical agents, combining various structural elements that can affect its biological properties and potential applications.

BTK-IN-39 (0204) is a PROTAC target protein ligand employed in the synthesis of PROTAC BTK Degrader-11.

CAS 2736510-62-4

(R)-3-(tert-Butyl)-N-[1-[4-[6-[6-(4-Boc-1-piperazinyl)-3-pyridyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-methylphenyl]ethyl]-1,2,4-oxadiazole-5-carboxamide

BTK-IN-39

Ref: TM-T201725